How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,399 results for

Six Item Cognitive Impairment Test

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

281. Male Sexual Dysfunction

., et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res, 1999. 11: 319. 89. Mulhall, J.P., et al. Validation of the erection hardness score. J Sex Med, 2007. 4: 1626. 90. Whooley, M.A., et al. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med, 1997. 12: 439. 91. Khera, M., et al. Diagnosis and Treatment of Testosterone (...) Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med, 2016. 13: 1787. 92. Davis-Joseph, B., et al. Accuracy of the initial history and physical examination to establish the etiology of erectile dysfunction. Urology, 1995. 45: 498. 93. Ghanem, H.M., et al. SOP: physical examination and laboratory testing for men with erectile dysfunction. J Sex Med, 2013. 10: 108. 94. Bhasin, S., et al. Testosterone therapy in men with androgen deficiency

2018 European Association of Urology

283. Practice Guideline Update Systematic Review Summary: Disorders of Consciousness

, the Huperzine A for the Treatment of Cognitive, Mood and Functional Deficits After Moderate and Severe TBI study, the INjury and TRaumatic STress (INTRuST) Consortium Neuroimaging Acquisition and Archival study, the NIDILRR for the Spaulding Harvard - Traumatic Brain Injury Model System and for Multicenter Evaluation of Memory Remediation after traumatic Brain Injury with Donepezil, the NINDS for Transforming Research and Clinical Knowledge in Traumatic Brain Injury study, James S. McDonnell Foundation (...) sponsored or cosponsored by Allergan Inc. and Merz Pharmaceuticals GmbH; performs botulinum neurotoxin procedures for treatment of focal spastic hypertonia ( 5 and 10 indicates that this result is 10 times more likely to be seen in a patient who has the target condition (e.g., MCS) than it is in a patient who does not. Conversely, the further the LR falls below 1, the less likely the patient is to have the condition (e.g., a test result with an LR+ 5), suggesting the study could not exclude

2018 American Academy of Neurology

284. Stroke in childhood - clinical guideline for diagnosis, management and rehabilitation

. The most important factor in stroke care in adults is being managed on a stroke unit by staff with specific expertise and interest in the disease. Stroke units have never been tested for childhood stroke and as a result are not even mentioned in these guidelines. Clot busting treatment for ischemic stroke, or clot removal, are becoming mainstays of care in adults, yet there is very little evidence for these treatments in children because research has not been done. These guidelines are the first stage (...) Antiphospholipid syndrome aPTT Activated partial thromboplastin time ARE Adverse radiation effects ARUBA trial A Randomised trial of Unruptured Brain Arteriovenous malformations AT Antitrypsin AVM Arteriovenous malformation AVPU scale ‘Alert, Voice, Pain, Unresponsive’ scale BoNTA Botulinum toxin A BP Blood pressure CA Catheter angiography CAF Common Assessment Framework CASP Critical Appraisal Skills Programme CBT Cognitive Behavioural Therapy CCC Comprehensive Care Centre CIMT Constraint Induced Movement

2017 Royal College of Paediatrics and Child Health

285. What national and subnational interventions and policies based on Mediterranean and Nordic diets are recommended or implemented in the WHO European Region, and is there evidence of effectiveness in reducing noncommunicable diseases?

. They do not necessarily reflect the official policies of the Regional Office.viii SUMMARY The issue Noncommunicable diseases (NCDs) are currently the leading cause of death globally. Of the six WHO regions, the WHO European Region is most affected by NCDs. The European Food and Nutrition Action Plan 2015–2020 aims to reduce preventable diet-related NCDs and all other forms of malnutrition prevalent in the Region through a whole-of-government, health-in-all-policies approach. It outlines a set (...) (against a 2010 baseline), of which target 7 is to “halt the rise in diabetes and obesity” (5,6). The 2030 Agenda for Sustainable Development also recognizes the global impact of NCDs, setting a target to reduce premature deaths from NCDs by one third by 2030 (Sustainable Development Goal (SDG) target 3.4) (7). Of the six WHO regions, the WHO European Region is the one most affected by NCDs. The prevalence and associated mortality for NCDs are high across all 53 Member States of the WHO European Region

2018 WHO Health Evidence Network

286. Treatment for Bipolar Disorder in Adults: A Systematic Review

.12423. PMID: 611908711. 2. Gum A, King-Kallimanis B, Kohn R. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication. Am J Geriat Psychiatry. 2009;17:769-81. 3. Samame C, Martino DJ, Strejilevich SA. Social cognition in euthymic bipolar disorder: systematic review and meta-analytic approach. Acta Psychiat Scand. 2012;125(4):266-80. 4. Sole B, Martinez-Aran A, Torrent C, et al. Are bipolar II patients cognitively impaired (...) relapse into acute episodes in adults with BD-I. • Depression treatment: Evidence was insufficient for drug treatments for depressive episodes in adults with BD-I and BD-II. • For adults with any BD type, cognitive behavioral therapy may be no better than other psychotherapies for improving acute bipolar symptoms and systematic/collaborative care may be no better than other behavioral therapies for preventing relapse of any acute symptoms. • Stronger conclusions were prevented by high rates

2018 Effective Health Care Program (AHRQ)

287. AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Aortic Valve Replacement

. Methods 17 3. Structural Program Requirements 19 3.1 Procedural Volume 19 3.2 Multidisciplinary Team (MDT) 20 3.2.1 Knowledge Base and Skills 21 3.3 Proceduralist Formalized Training 23 3.4 Facilities and Institutional Resources 24 4. Process Program Requirements 28 4.1 Patient Selection Requirements 29 4.1.1 MDT Patient Case Conference Requirements 30 4.1.1.1 Operational Details 32 4.1.2 Patient Selection Considerations 34 4.1.2.1 Frailty, Cognition, Quality of Life, Immobility and Disability 35 (...) quality assessment/quality improvement processes are well established in the STS Adult Cardiac Surgery Database for SAVR programs. a. The metrics for assessment of TAVR site performance are not yet at a state of maturity as compared to SAVR and the STS star rating system. Similar Bavaria JE, et al. TAVR Recommendations and Requirements 7 performance metrics are under development for TAVR by the STS/ACC and should be tested and implemented when feasible. b. In addition, one-year patient outcomes

2018 Society for Cardiovascular Angiography and Interventions

288. Prostate Cancer

in the Era of the U.S. Preventive Services Task Force Recommendation against Prostate Specific Antigen Based Screening. J Urol, 2016. 195: 66. 91. Grossman, D.C., et al. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. Jama, 2018. 319: 1901. 92. U.S. Preventive Services, Task Force. Prostate Cancer Screening Draft Recommendations. 2017. 93. Arnsrud Godtman, R., et al. Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 (...) years in the Goteborg randomized population-based prostate cancer screening trial. Eur Urol, 2015. 68: 354. 94. Ilic, D., et al. Screening for prostate cancer. Cochrane Database Syst Rev, 2013. 1: CD004720. 95. Hayes, J.H., et al. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. JAMA, 2014. 311: 1143. 96. Booth, N., et al. Health-related quality of life in the Finnish trial of screening for prostate cancer. Eur Urol, 2014. 65: 39. 97. Vasarainen, H

2018 European Association of Urology

289. Chronic Pelvic Pain

., et al. Trauma and medically unexplained symptoms towards an integration of cognitive and neuro-biological accounts. Clin Psychol Rev, 2007. 27: 798. 54. Walker, E.A., et al. Psychiatric diagnoses and sexual victimization in women with chronic pelvic pain. Psychosomatics, 1995. 36: 531. 55. Nickel, J.C., et al. Childhood sexual trauma in women with interstitial cystitis/bladder pain syndrome: a case control study. Can Urol Assoc J, 2011. 5: 410. 56. Paras, M.L., et al. Sexual abuse and lifetime (...) ., et al. Associations Between Penetration Cognitions, Genital Pain, and Sexual Well-being in Women with Provoked Vestibulodynia. J Sex Med, 2016. 13: 444. 93. Roth, R.S., et al. Psychological factors and chronic pelvic pain in women: a comparative study with women with chronic migraine headaches. Health Care Women Int, 2011. 32: 746. 94. Souza, P.P., et al. Qualitative research as the basis for a biopsychosocial approach to women with chronic pelvic pain. J Psychosom Obstet Gynaecol, 2011. 32: 165

2018 European Association of Urology

290. Best Practices across the Continuum of Care for the Treatment of Opioid Use Disorder

assessment (i.e., do not address mental health, physical concerns, etc.). There is no consensus on best practice. 39,40 • Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): eight-item measure that can be used in primary care settings to identify risk related to the use of 10 different substances across all levels of severity 41 • CAGE-Adapted to Include Drugs (CAGE-AID): four-item measure to predict substance use disorders in primary care context 42 • Drug Abuse Screening Test (DAST): 10 (...) . This appendix highlights only that information encountered as part of a general search. To determine best practices for these populations, an in-depth, targeted literature search and synthesis would need to be completed. Screening Youth viii ? Multiple tools are available, but there is no consensus on best practice. ? Adolescent Alcohol and Drug Involvement Scale (AADIS): interview to determine if assessment of alcohol or other drug use is needed 68 ? CRAFFT: six-item measure to screen for substance use

2018 Canadian Centre on Substance Abuse

291. Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU Full Text available with Trip Pro

refer to our Privacy Policy. Toggle navigation Articles & Issues Collections For Authors Journal Info > > Clinical Practice Guidelines for the Prevention and Manageme... Email to a Colleague Colleague's E-mail is Invalid Your Name: (optional) Your Email: Colleague's Email: Separate multiple e-mails with a (;). Message: Thought you might appreciate this item(s) I saw at Critical Care Medicine. Send a copy to your email Your message has been successfully sent to your colleague. Some error has occurred (...) while processing your request. Please try after some time. Article Tools Share this article on: Email to a Colleague Colleague's E-mail is Invalid Your Name: (optional) Your Email: Colleague's Email: Separate multiple e-mails with a (;). Message: Thought you might appreciate this item(s) I saw at Critical Care Medicine. Send a copy to your email Your message has been successfully sent to your colleague. Some error has occurred while processing your request. Please try after some time. Export to End

2018 Society of Critical Care Medicine

292. End-of-Life Care for People Experiencing Homelessness

walks, assess his or her gait, stability and risk for falls, ability to sit and stand, general strength, and nutritional status. Assess if the patient needs assistive devices, such as a cane, walker, or wheelchair. Perform focused exams as indicated. Consider the use of validated exams to evaluate strength or risk of falls, such as i. Get Up and Go Test: https://www.ons.org/sites/default/files/TUG_Test-a.pdf ii. Physical Performance Test (9 items): http://www.brightonrehab.com/wp- content/uploads (...) . A patient’s mental status can be assessed by his or her responses during conversation and through different tools, such as those listed below. Health Care for the Homeless Clinicians’ Network ADAPTING YOUR PRACTICE Recommendations for End-of-life Care for People Experiencing Homelessness 17 i. Mini Mental Status Exam—A screening tool for assessing cognitive impairment: https://www.mountsinai.on.ca/care/psych/on-call-resources/on-call- resources/mmse.pdf ii. A common, simple assessment is to assess whether

2018 National Health Care for the Homeless Council

293. Pharmacological treatment for memory disorder in multiple sclerosis

of the central nervous system (CNS) and can cause both neurological and neuropsychological disability. Both demyelination and axonal and neuronal loss are believed to contribute to MS‐related cognitive impairment. Memory disorder is one of the most frequent cognitive dysfunctions and presents a considerable burden to people with MS and to society due to the negative impact on function. A number of pharmacological agents have been evaluated in many existing randomised controlled trials for their efficacy (...) language summary available in Pharmacological agents as symptomatic treatment for memory disorder in people with multiple sclerosis This is an update of the Cochrane review "Pharmacologic treatment for memory disorder in multiple sclerosis" (first published in The Cochrane Library 2011, Issue 10). Background Memory disorder is one of the most frequent cognitive impairments (where people have difficulty with thinking, learning and memory) in people with multiple sclerosis (MS), affecting an estimated 40

2018 European Academy of Neurology

294. COPD Disease Education in Pulmonary Rehabilitation: A Workshop Report

and 0 false. Scoring based on percentage of items answered correctly. Test retest r=0.71 15–20 Cronbach’s a=0.73 COPD-Q (32) Assesses knowledge of COPD. 13 items, scores range from 0 to 13 based on correct responses; higher scores indicate greater correct responses. Test retest ICC=0.90 Not available Cronbach’s a=0.72 LINQ (33) Assesses patients’ need for information about their COPD to guide clinical encounters. Six domains include: disease knowledge; medicines; self- management; smoking; exercise (...) to PR after hospitalization for exacerbation. Given the current state of knowledge on cognitive impairment associated with COPD,individualsshouldbeconsideredfor screening cognitive function upon entry to PR. Screening will allow the HCP to understandtheindividualenrollinginPRin order to tailor educational activities to their cognitive status. Furthermore, a referral for a comprehensive neuropsychological evaluation can be facilitated when concerns are noted. Several types of screening tests

2018 American Thoracic Society

295. Nonsurgical Treatments for Urinary Incontinence in Women: A Systematic Review Update

network meta-analysis findings. We took two major approaches to ensure that our conclusions are consistent with clinical logic and with the evidence base. First, based on current guidelines, 7, 8 we categorized interventions based on whether they are used primarily for stress UI or for urgency UI (or both) and whether they are typically used as first-, second-, or third-line interventions. From the overall network meta-analyses, we summarized six (overlapping) sets of comparisons: 1) stress UI

2018 Effective Health Care Program (AHRQ)

296. Cladribine (Mavenclad) - multiple sclerosis

with mild or moderate dexterity impairments and testing all the handling steps that patients should perform in order to open the packaging and retrieve a tablet. In general the results showed that patients rated that packaging gets easier to open after each use (i.e. they become more experienced with the method to open the packaging). In addition, the testing shows that even under circumstances where patients either do not read the instructions or misunderstand them, the packaging is still intuitive (...) Multiple Sclerosis PT Preferred Term PY Patient Years SAE Serious Adverse Event s.c./SC Subcutaneous SD Standard Deviation SE Standard Error SF-36 Short Form 36 Item SmPC Summary of Product Characteristics SOC System Organ Class SPMS Secondary Progressive Multiple Sclerosis SIR Standardized Incidence Ratio t 1/2 Apparent elimination half-life TB Tuberculosis TEAE Treatment-Emergent Averse Event t max Time to reach maximum plasma concentration Assessment report EMA/435731/2017 Page 6/131 1. Background

2017 European Medicines Agency - EPARs

297. Enhancing Equitable Access to Assistive Technologies in Canada

in Canada therefore provides an opportunity to address policy priorities focused on helping older adults age in place. Assistive technologies can be used for a variety of health- related goals, including for the promotion of self- management and independence, and performing daily tasks by compensating for physical, sensory and cognitive impairments. While priorities and policies in provincial and territorial health systems in Canada focus on expanding the home and community care sector and supporting (...) Canadians, but (where possible) it also gives particular attention to two groups: • people living with a disability (includes cognitive impairments, intellectual disabilities, mental health or substance abuse problems, and vision and hearing impairment); and • people living in rural/remote communities. Many other groups warrant serious consideration as well, and a similar approach could be adopted for any of them. † The PROGRESS framework was developed by Tim Evans and Hilary Brown (Evans T, Brown H

2017 McMaster Health Forum

298. Identifying and Assessing Core Components of Collaborative-care Models for Treating Mental and Physical Health Conditions

with the presence of a non- communicable disease, there is a multiplicative effect on mortality and morbidity.(1) In addition, premature mortality has been found to be up to 38% higher in those with diabetes and depression than in those with diabetes alone.(13) These individuals also tend to have poorer self-care (i.e., maintenance of diet, regular exercise, and taking medications as prescribed), and increased medical symptom burden and greater functional impairment.(14) There are also impacts beyond the health (...) from Ontario found that individuals with schizophrenia and diabetes received diabetes care that was significantly sub-optimal compared with those without schizophrenia in relation to guideline-concordant testing for HbA1c, lipid testing and eye exams);(16) • overuse of some types of services (such as increased rates of intensive-care-unit admissions, ambulatory care, and emergency department visits);(14; 16) and • high risk of medical errors.(17) While there are a number of reasons for the delivery

2017 McMaster Health Forum

299. Advancing Care - Research with care homes

impairment. Just under half of those people had their vision corrected by glasses, and more would have had their vision corrected by cataract surgery. good vision is important, for example in preventing other health problems such as falls. But it seems that relatives and care staff, as well as optometrists themselves, may be assuming incorrectly that people with dementia are unable to complete a sight test. reAd MOre (Study 18) The study showed that more than 80% of the people living with dementia who (...) centres. The majority have 35 beds or fewer. The population of care home residents has changed dramatically over the last five to ten years, to include people living with severe frailty and illness. The average care home resident is likely to be female, aged 85, and have a life expectancy of 12-30 months. He or she may have six or more diagnoses, may be taking seven or more medications, and live with physical disabilities and mental health problems. The majority live with dementia and many experience

2017 NIHR Dissemination Centre - Themed Reviews

300. Mental health care in the perinatal period: Australian clinical practice guideline

mental health conditions are able to parent effectively and the majority of infants are not specifically disadvantaged. However, mental health conditions in their more severe form are often associated with impaired functioning, especially in relation to a woman’s ability to care for her infant and the formation of secure infant attachment, which may in turn be associated with poorer social, cognitive, and behavioural outcomes in the child (1st 1001 Days APPG 2015). Aim and scope of the Guideline (...) in the broader clinical assessment. xi CBR Undertake psychosocial assessment in conjunction with a tool that screens for current symptoms of depression/ anxiety (i.e. the EPDS). xii CBR Consider language and cultural appropriateness of any tool used to assess psychosocial risk. x CBR As part of the clinical assessment, use anxiety items from screening tools (e.g. EPDS items 3, 4 and 5, Depression, Anxiety and Stress Scale (DASS) anxiety items and Kessler Psychological Distress Scale (K-10) items 2, 3, 5

2018 Clinical Practice Guidelines Portal

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>